OPH_2005_219_SINDEX.indd Fax +41 61 306 12 34 E-Mail karger@karger.ch www.karger.com 421 Subject Index Vol. 219, 2005 Chromovitrectomy 251 Clinical trial, age-related macular degeneration 154 Coats’ disease 401 Coenzyme Q10 154 Conjunctival malignancy 177 Contact lenses 72 Continuous circular capsulorhexis 338 Cornea 324 Corneal fl ap 276 Cryptococcosis 101 Cyclooxygenase 2 inhibitor 243 Dacryocystorhinostomy, long-term patient satisfaction 97 Decentration, intraocular lens 26 Deep sclerectomy 281 Diabetes 1, 394 Diabetic cataracts 309 – macular edema 86, 206 – maculopathy 16 – retinopathy 107, 292 – – screening 292 Diffuse macular edema 394 Digital subtraction angiogram 136 Dissociated optic nerve fi ber layer appearance 206 Driving abilities 191 Drusen 154 Dry eye 276 Elderly patients, psuedouveitis/uveitis 263 Electrolytes 142 Emmetropization 226 Encephalitis 119 Endoillumination 338 Epiphora 136 Episcleral venous pressure 357 Evisceration 177 Exenteration 177 Exodeviation 237 Exophthalmos 181 Eyelid 57 Eye stabilization 401 Fatty acids (n–3) 154 Fibrous dysplasia 181 Fixation stability 16 Fluorescein angiography 86, 303, 350, 366 Foveal exudate 366 Fuchs’ heterochromic uveitis 21 Fucose 324 Acetyl- L -carnitine 154 Achromatic perimetry 202 A constant, intraocular lenses 390 Acute retinal necrosis 272 Adjustable intraocular lens 362 Adrenomedullin 107 Age-related macular degeneration 154, 214, 303 Agreement, intraocular pressure measurements 36 Amniotic membrane 297 Ankle-brachial index 334 Anterior segment surgery 129 Antibiotics, neonatal chlamydial conjunctivitis 232 Antioxidants 49, 309 Aponeurosis advancement 129 Apoptosis 1 Aqueous fl are 21 – humor outfl ow 357 Argon laser 267 Arterial stiffness 334 Arteriosclerosis 334 Arteriovenous crossing 386 Astrocytic hamartoma 350 Autofl uorescence, astrocytic hamartoma 350 Basal cell carcinoma 57 Blepharoplasty 185 Blepharoptosis 129 Blindness 345 Blood-aqueous barrier 21 Blood fl ow, normal-tension glaucoma 317 Blue-on-yellow perimetry 202 Branch retinal vein obstruction 386 – – – occlusion 267, 334 Bupivacaine 167 Cataract prevention/reversal 309 – surgery 167, 362, 390 CD44 receptors 287 Central retinal vein occlusion 267 – serous chorioretinopathy 202 Cerebral-cortex-derived neural stem cells 171 Cerebrospinal fl uid 101 Chlamydia pneumoniae 232 – trachomatis 232 Chorioretinal venous anastomosis 267 Choroid 287 Choroidal neovascular membranes 214 © 2005 S. Karger AG, Basel Accessible online at: www.karger.com/oph Functional magnetic resonance imaging, lateral geniculate nucleus function 11 Glaucoma 1, 26, 357, 373, 413 Growth hormone defi ciency 226 Healthy menstruating women, visual fi eld changes 30 Hepatitis B virus 93 Herpes zoster ophthalmicus 272 High altitude, macula changes 404 Hinge position, dry eye 276 Homelessness, eye disease risk 345 Homonymous hemianopia 11 Hyaluronan 287 – synthetase 287 Hypertension 366 Indocyanine green angiography 303, 350 – –, macular hole treatment 251 Infl uenza 119 Informed consent, blepharoptosis 129 Internal limiting membrane 251 – – – removal 206 Intracameral anesthesia 167 Intraocular lenses 72, 362, 390 – methotrexate 54 – pressure 36, 317, 413 Intravitreal cortisone 394 – triamcinolone 413 Lacrimal draining system 136 – pathway obstruction 232 – stenosis 136 Large initial overcorrection, exotropia surgery 237 Laser in situ keratomileusis 276 – photocoagulation 401 Lateral geniculate nucleus 11 Lens power calculation formulas 390 Leptin 107 Lidocaine gel 167 Light sensitivity 16 Limbal stem cell transplantation 297 �-Lipoic acid 49 Long-term vitreous replacement 147 Macula dysfunction 404 Macular hole 251 Matrix metalloprotease-9 upregulation 324 Microperimetry, diabetic maculopathy 16 Subject IndexOphthalmologica Vol. 219, 2005422 Mitochondria 154 Mitomycin C 281 Mouse model, cataract formation inhibition 309 Multifocal electroretinography 404 Multiple myeloma 43 Nasolacrimal duct obstruction 142 Neonatal conjunctivitis 232 Non-mydriatic digital photography, diabetic retinopathy screening 292 Normal-tension glaucoma 317 Oblique vision 115 Occult choroidal neovascularization 303 Ocular burns 297 Open-angle glaucoma 1 Optical coherence tomography 80, 86, 379, 404 Optic nerve atrophy 345 – – head photography 80 Orbital compression 181 – invasion, conjunctival squamous cell carcinoma 177 Oxidative stress 309 Palinopsia 115 Paracentral scotoma 191 Pars plana vitrectomy 206 Pediatric benign lid lesions 112 – cataract 72 Peduncular hallucinosis 115 Perfl uorohexyloctane (F 6 H 8 ) 147 Perimetry simulation 123 Perioperative posterior ischemic optic neuropathy 185 Perisim 2000 123 Phacoemulsifi cation 21, 338 Phacotrabeculectomy 26 Photoreceptors 171 Poverty, eye disease risk 345 Pregnancy , intraocular pressure measurements 36 Proliferative vitreoretinopathy 107 Pseudouveitis 263 Psoralen-UVA therapy, oxidative damage 49 Pulse wave velocity, brachial ankle 334 Punch trabeculectomy 281 Pyruvate 309 Reconstructive surgery, eyelid malignancies 57 Refraction 226 Refractive lens surgery 362 Retinal arterial macroaneurysms 366 – choroidal anastomosis 303 – nerve fi ber layer thickness 80, 379 – stem cells 171 – thickness 379 – vascular anomalous complex 303 – vein occlusion 243 – vessels 386 Retinitis 119 Retrograde degeneration, lateral geniculate nucleus 11 Rhegmatogenous retinal detachment 222 Rofecoxib 243 Short-wavelength perimetry, healthy menstruating women 30 Silicone oil 147 Slit-lamp biomicroscopy, diabetic retinopathy 292 Squamous cell carcinoma 177 Standard achromatic perimetry, healthy menstruating women 30 STAT3 protein 214 Subepidermal calcifi ed nodules 112 Subretinal fl uid 222 – strand 222 Tear proteins 142 Tenascin 214 Tendency-oriented perimetry program 123 Three-dimensional dacryocystography 136 – rotational angiography 136 Topical anesthesia, cataract surgery 167 Transforming growth factors 171, 222 Trypan blue 338 Tuberous sclerosis 350 Ultraviolet A radiation, oxidative damage 49 Uveitis 54, 263 Varicella-zoster virus 272 Vioxx 243 Viral infection, retinitis 119 Visual acuity 86, 154 – cortex 11 – fi eld 154, 373 – – defects, central/paracentral 191 – hallucinations 115 – loss 185 – pseudohallucinations 115 Vitreous 93 – hemorrhage 338 Wound healing 324